PARAGON-HF Clinical Trial Eligibility in a Population of Patients Hospitalized With Heart Failure: HFpEF Eligibility for PARAGON-HF

Sabina Sayeed; Marat Fudim; Adam D. Devore; Haolin Xu; Roland A. Matsouaka; Paul A. Heidenreich; Clyde W. Yancy; Gregg C. Fonarow; Adrian F. Hernandez

doi:10.1016/j.cardfail.2019.10.003

PARAGON-HF Clinical Trial Eligibility in a Population of Patients Hospitalized With Heart Failure: HFpEF Eligibility for PARAGON-HF

Sabina Sayeed, Marat Fudim, Adam D. Devore, Haolin Xu, Roland A. Matsouaka, Paul A. Heidenreich, Clyde W. Yancy, Gregg C. Fonarow, Adrian F. Hernandez^*

^*Corresponding author for this work

Medicine, Cardiology Division

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Original language	English (US)
Pages (from-to)	1009-1011
Number of pages	3
Journal	Journal of Cardiac Failure
Volume	25
Issue number	12
DOIs	https://doi.org/10.1016/j.cardfail.2019.10.003
State	Published - Dec 2019

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.cardfail.2019.10.003

Cite this

@article{fc9b2c900bf34c8fa77daee4fff5adda,

title = "PARAGON-HF Clinical Trial Eligibility in a Population of Patients Hospitalized With Heart Failure: HFpEF Eligibility for PARAGON-HF",

author = "Sabina Sayeed and Marat Fudim and Devore, {Adam D.} and Haolin Xu and Matsouaka, {Roland A.} and Heidenreich, {Paul A.} and Yancy, {Clyde W.} and Fonarow, {Gregg C.} and Hernandez, {Adrian F.}",

note = "Funding Information: Funding: M. Fudim is supported by an American Heart Association Grant 17MCPRP33460225 and NIH T32 Grant 5T32HL007101. Funding Information: The Get With The Guidelines{\textregistered}-Heart Failure (GWTG-HF) program is provided by the American Heart Association. GWTG-HF is sponsored, in part, by Amgen Cardiovascular and has been funded in the past through support from Medtronic, GlaxoSmithKline, Ortho-McNeil, and the American Heart Association Pharmaceutical Roundtable. Powered by IQVIA, Cambridge, MA. Duke Clinical Research Institute (DCRI) served as the data analysis center.",

year = "2019",

month = dec,

doi = "10.1016/j.cardfail.2019.10.003",

language = "English (US)",

volume = "25",

pages = "1009--1011",

journal = "Journal of Cardiac Failure",

issn = "1071-9164",

publisher = "Churchill Livingstone",

number = "12",

}

TY - JOUR

T1 - PARAGON-HF Clinical Trial Eligibility in a Population of Patients Hospitalized With Heart Failure

T2 - HFpEF Eligibility for PARAGON-HF

AU - Sayeed, Sabina

AU - Fudim, Marat

AU - Devore, Adam D.

AU - Xu, Haolin

AU - Matsouaka, Roland A.

AU - Heidenreich, Paul A.

AU - Yancy, Clyde W.

AU - Fonarow, Gregg C.

AU - Hernandez, Adrian F.

N1 - Funding Information: Funding: M. Fudim is supported by an American Heart Association Grant 17MCPRP33460225 and NIH T32 Grant 5T32HL007101. Funding Information: The Get With The Guidelines®-Heart Failure (GWTG-HF) program is provided by the American Heart Association. GWTG-HF is sponsored, in part, by Amgen Cardiovascular and has been funded in the past through support from Medtronic, GlaxoSmithKline, Ortho-McNeil, and the American Heart Association Pharmaceutical Roundtable. Powered by IQVIA, Cambridge, MA. Duke Clinical Research Institute (DCRI) served as the data analysis center.

PY - 2019/12

Y1 - 2019/12

UR - http://www.scopus.com/inward/record.url?scp=85075939914&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075939914&partnerID=8YFLogxK

U2 - 10.1016/j.cardfail.2019.10.003

DO - 10.1016/j.cardfail.2019.10.003

M3 - Letter

C2 - 31626949

AN - SCOPUS:85075939914

VL - 25

SP - 1009

EP - 1011

JO - Journal of Cardiac Failure

JF - Journal of Cardiac Failure

SN - 1071-9164

IS - 12

ER -

PARAGON-HF Clinical Trial Eligibility in a Population of Patients Hospitalized With Heart Failure: HFpEF Eligibility for PARAGON-HF

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this